Insulin/Insulin-like Growth Factor-I and Estrogen Cooperate to Stimulate Cyclin E-Cdk2 Activation and Cell Cycle Progression in MCF-7 Breast Cancer Cells through Differential Regulation of Cyclin E and p21WAF1/Cip1
Open Access
- 1 July 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (28), 25823-25833
- https://doi.org/10.1074/jbc.m100925200
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A Pure Estrogen Antagonist Inhibits Cyclin E-Cdk2 Activity in MCF-7 Breast Cancer Cells and Induces Accumulation of p130-E2F4 Complexes Characteristic of QuiescenceJournal of Biological Chemistry, 2000
- Role of the Insulin-Like Growth Factor Family in Cancer Development and ProgressionJNCI Journal of the National Cancer Institute, 2000
- Insulin-like Growth Factor-1 (IGF-1) Receptor-Insulin Receptor Substrate Complexes in the UterusPublished by Elsevier ,1998
- Insulin Receptor Substrate-1 is the Predominant Signaling Molecule Activated by Insulin-like Growth Factor-I, Insulin, and Interleukin-4 in Estrogen Receptor-positive Human Breast Cancer CellsPublished by Elsevier ,1998
- Mitogenic Signaling of Insulin-like Growth Factor I in MCF-7 Human Breast Cancer Cells Requires Phosphatidylinositol 3-Kinase and Is Independent of Mitogen-activated Protein KinaseJournal of Biological Chemistry, 1997
- New functional activities for the p21 family of CDK inhibitors.Genes & Development, 1997
- Pure Antiestrogens The Most Important Advance in the Endocrine Therapy of Breast Cancer since 1896?aAnnals of the New York Academy of Sciences, 1996
- Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1Nature, 1995
- Oestradiol treatment increases the sensitivity of MCF-7 cells for the growth stimulatory effect of IGF-IThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells.Journal of Clinical Investigation, 1992